CRL
NYSE · Life Sciences Tools & Services
Charles River Laboratories
$279.01
+0.95 (+0.34%)
Analyst Consensus
Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
-74.5% upside
Low Target
$57.45
Average Target
$71.21
High Target
$105.86
Current Price
$279.01
Current
$279.01
$279.01
Target
$71.21
$71.21
$57.45
$71.21 avg
$105.86
Scenario Analysis
Bear Case
$57.45
-79.4%
Low target
Base Case
$71.21
-74.5%
Avg target
Bull Case
$105.86
+-62.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$303.31
-8.0% from high
52-Week Low
$144.26
+93.4% from low
50-Day SMA
$200.46
+39.2% vs SMA
200-Day SMA
$169.92
+64.2% vs SMA
RSI (14)
21.1
Oversold
Target vs 52W High
$71.21
-76.5% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -44.0% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -26.7% |
| IQV | Strong Buy | 28 | 82% | $82.96 | -69.3% |
| A | Strong Buy | 30 | 77% | $64.69 | -60.1% |
| WAT | Buy | 31 | 65% | $189.60 | -55.3% |
| ILMN | Buy | 28 | 57% | $169.36 | -29.1% |
| MTD | Hold | 19 | 53% | $170.43 | -88.1% |
| WST | Strong Buy | 23 | 91% | $136.24 | -62.3% |